Dialectic Behaviour Therapy (DBT) for People With Autism: A Multiple Baseline Single Case Design
DGT-ASS
1 other identifier
interventional
6
1 country
1
Brief Summary
The goal of this experimental study is to test the effectiveness of Dialectic Behavioural Therapy in patients with Autism Spectrum Disorder. The aim questions are:
- Follow DBT of 10 months
- Keep a diary on their urge of maladaptive emotion regulation strategies and well-being
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 12, 2026
CompletedFirst Posted
Study publicly available on registry
August 26, 2026
CompletedStudy Start
First participant enrolled
September 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2027
Study Completion
Last participant's last visit for all outcomes
February 1, 2028
August 26, 2026
July 1, 2026
11 months
August 12, 2026
August 25, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Maladaptive Emotion Regulation Strategies (MERS) measured assessed by the DBT diary (Linehan, 2016)
MERS is the average of the urge to six maladaptive emotion regulation strategies: 1. suicidal thoughts/behaviours 2. self-harm, 3. eating problems 4. substance abuse 5. anger outburst 6. other All emotion regulation strategies are measured on a scale from 0 - 100. MERS will be created by adding scores of the six strategies together and divide it by 6.
From enrollment to end of treatment at 10 months
Emotional well-being as assessed by the DBT diary (Linehan, 2016)
The daily diary measures emotional suffering and happiness on a scale from 0 - 100. Emotional suffering is inverted, following the logic that higher emotional suffering means lower emotional well-being. The variable well-being is created by averaging the invert of emotional suffering and happiness.
From enrollment to end of treatment at 10 months
Secondary Outcomes (3)
Social behaviour
At start of baseline (T1), at end of treatment phase at 10 months (T2)
Emotion regulation
At the start of the baseline phase (T1), at the end of the treatment phase at 10 months (T2)
Generic psychopathology and functioning
At the start of the baseline phase (T1), at the end of the treatment phase at 10 months (T2)
Study Arms (1)
Dialectic Behavioural Therapy
EXPERIMENTALDialectic Behavioural Therapy for emotion regulation, adapted to individuals with Autism Spectrum Disorder, given for 10 months
Interventions
Dialectic Behavioural Therapy for emotion regulation, adapted to individuals with Autism Spectrum Disorder
Eligibility Criteria
You may qualify if:
- DSM-5 diagnosis of ASD
- Sufficient understanding, as demonstrated in conversation with intake therapist;
- Explicit behavioural problems, which, according to patient and therapist, lead to functional problems (like suicidal ideation, auto mutilation, emotional outburst and interpersonal conflicts);
- BMI \> 17;
- Commitment to the therapy and shared goals as assessed by intake therapist;
You may not qualify if:
- Antisocial behaviour which interrupts the group climate;
- Presence of a trauma-related disorder that is likely to interfere with the ability to engage effectively in DBT or that requires specialized trauma-focused treatment prior to or alongside DBT as assessed by intake team;
- Excessive dependency on substances for which no parallel appropriate policy can be made;
- Diagnosis of psychotic disorder if not stable;
- Diagnosed with bipolar disorder.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- GGZ Frieslandlead
Study Sites (1)
GGZ Friesland
Leeuwarden, Provincie Friesland, 8934AD, Netherlands
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 12, 2026
First Posted
August 26, 2026
Study Start (Estimated)
September 1, 2026
Primary Completion (Estimated)
August 1, 2027
Study Completion (Estimated)
February 1, 2028
Last Updated
August 26, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share
To protect the participants of the study